Chondroïtine sulfate sodique in food supplements
88 supplements declared in France contain Chondroïtine sulfate sodique as a substance or active ingredient.
Other names in the Compl'Alim list: chondroïtine, sodium chondroitin sulfate.
Compl'Alim declarations. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
In plain words
À quoi il sert, selon les fabricants
Objectives most often stated for supplements that contain it (Chondroïtine sulfate sodique): articulations (71 produits), os (17 produits), sport (4 produits), antioxydant (2 produits), cheveux et ongles (2 produits).
These are the objectives manufacturers declared to the authorities, not proven effects. On the packaging, only health claims authorised by the EU may be written.
Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
What the registers say, country by country
Each line repeats what an official register says on the date it was consulted. Not being in a register means neither allowed nor banned.
Compl'Alim ingredient list (France): listed.
Compl'Alim, reference list of ingredients, retrieved 21 October 2026.
Canada, licensed natural health products (LNHPD): 6 products.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
United States, supplement labels (DSLD; supplements need no prior approval): 24 products.
Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Poland, notified supplements: 1 product.
GIS, products notified in Poland, retrieved 27 October 2026.
Główny Inspektorat Sanitarny (GIS), Rejestr produktów objętych powiadomieniem
Taiwan, registered products: 2 products.
TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.
Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0
What we know about this ingredient
Scientific publications (PubMed)
8 records published in the five years before 12 November 2026. The name is searched in the title or abstract; derivatives and passing mentions can be counted. This count does not measure effectiveness.
Searched on 12 November 2026.
Products
- Gastriconfort comprimé, declared in 2026
- Glucosamine & Chondroitin Bulk, comprimé, declared in 2024
- Glucosamine & Chondroitin with MSM NOW Foods, gélule, declared in 2026
- Glucosamine Chondroïtine Cuure, gélule, declared in 2025
- Glucosamine Chondroïtine 2000 mg - Gélules végétales Compagnie des Sens, gélule, declared in 2026
- Glucosamine Complex comprimé, declared in 2025
- HORBÄACH - GLUCOSAMINE & CHONDROITIN comprimé, declared in 2026
- HORBÄACH - HIGH STRENGTH GLUCOSAMINE CHONDROITIN COMPLEX comprimé, declared in 2025
- Joint Supp gélule, declared in 2026
- MYOSTÉO CONFORT ARTICULAIRE ampoule, declared in 2024
- Nutron comprimé, declared in 2026
- OXYFLEX gélule, declared in 2026
- Orthomol arthroplus Orthomol arthroplus, poudre, flavour orange, declared in 2025
- Ostéo-rhumal gélule, declared in 2025
- Régénum gélule Lorica, gélule, declared in 2026
- Réponse articulaire Pollenergie, gélule, declared in 2025
- SI21 ARTICULATIONS NAT & BEAUTY, flacon, declared in 2025
- SILICIUM ORGANIQUE + MSM SFB LABORATOIRES, flacon, declared in 2026
- SYNERTHROSE gélule, declared in 2024
- Wella comprimé, declared in 2026
- oroflex DUO Nut'exel, autre : gélule + capsule, declared in 2024
- silamax articulaire gélule labosantésilice, gélule, declared in 2024
- ARTICARTIL MEDILAB, gélule, withdrawn from the market
- Arthro2vie poudre, earlier declaration, replaced by the 2025 declaration
- Cartilage de requin NaturAvignon Laboratoire, sachet, earlier declaration, replaced by the 2026 declaration
- Régénum Lorica, gélule, earlier declaration, replaced by the 2024 declaration
- Régénum gélule Lorica, gélule, earlier declaration, replaced by the 2026 declaration
- Régénum gélules Lorica, gélule, withdrawn from the market